Terveystalo Plc, INSIDE INFORMATION, 8 June 2026 at 08:00 (EEST)

Inside information: Terveystalo updates its strategic focus, financial targets for the medium term and dividend policy

Terveystalo Plc's ("Terveystalo") Board of Directors has approved the company's updated strategic focus, financial targets, and profit distribution policy for the medium term. The updated targets reflect the company's renewed focus on growth in selected healthcare verticals and on scaling its leading digital solutions across healthcare retail to drive value creation.

Renewed strategic focus on growth and digital engagement

Terveystalo updates its strategic focus and introduces a new strategic framework, ARC: AI and data-powered, Reach through growth and access and Customer-centricity. In this new framework, Terveystalo will focus on four strategic shifts:

• Value creation: Terveystalo is shifting its focus from margin optimisation alone to pursuing profitable growth in selected healthcare verticals.

• Services and pricing: On the services and pricing side, the company is moving from a transactional service model to an easy-to-use retail approach that is more accessible to customers.

• Delivery model: In terms of its delivery model, Terveystalo is sharpening its focus from a broad generalist offering to outpatient specialist care and digital growth.

• Customer engagement: On customer engagement, the company is transitioning from reactive service provision to building proactive customer engagement and loyalty.

Together, these shifts provide the foundation for sustainable value creation for customers and investors alike.

Updated medium term financial targets and dividend policy

Terveystalo's updated [medium term] financial targets and dividend policy are as follows:

Profitable growth:

• Terveystalo targets Adjusted EPS growth of 10% p.a. on average

Moderate leverage ratio:

• Terveystalo Group's leverage target (Net Debt/Adj. EBITDA) is set at no more than 3x.
• Indebtedness may temporarily surpass the target level, particularly in conjunction with large acquisitions.

Profit distribution:

• Terveystalo aims annually to distribute at least 50% of net result, either as dividends or through share buy-backs, and to deliver growing, attractive shareholder returns in line with growing EPS.
• The dividend proposal must consider the company's long-term potential and financial status.

Previous financial targets set in 2024 were:

• EPS to grow on average by 10% p.a.
• Net debt to EBITDA not to exceed 2.5x. Indebtedness may temporarily surpass the target level, particularly in conjunction with acquisitions.
• At least 80% of net result to be distributed as dividends. The dividend proposal must consider the company's long-term potential and financial status.

President and CEO Ville Iho: "With our updated Strategy, ARC, we are taking the next step in Terveystalo's growth journey. We are shifting our focus from margin improvement alone to profitable growth in the most attractive verticals. At the same time, we are strengthening our model through a more accessible retail approach, a sharper focus on outpatient specialist and digital services, and deeper customer engagement and loyalty. We see significant opportunities to expand selected specialities, such as dental and eye care and to scale digital health retail into a stronger growth engine for the group. These are growth areas where customers value quality, accessibility, and convenience - and where our brand, professional excellence, and digital capabilities give us a strong foundation for growth. The updated financial targets reflect our renewed focus on growth along with sustainable value creation for customers and investors alike."

Chair of the Board of Directors Kari Kauniskangas: "The Board's priority is to ensure that Terveystalo allocates capital to the most attractive opportunities to create long-term shareholder value. The updated strategic direction sharpens the company's focus on scalable growth areas, such as dental, eye care and digital health retail, where we see strong market potential and opportunities to build competitive advantage. Combined with disciplined capital allocation and clear financial targets, this strategy provides a strong foundation for sustainable value creation."

Terveystalo plans to host a Capital Markets Day in November 2026 to discuss the next steps of the growth strategy and the updated financial targets.

Helsinki 8 June 2026

Terveystalo Plc
Board of Directors

For more information, please contact:

Kati Kaksonen,
Vice President, Investor Relations and Sustainability
Tel. 010 345 2034
kati.kaksonen@terveystalo.com

Distribution:

Nasdaq Helsinki Oy
Principal media
www.terveystalo.com